Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.97
+0.20 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 16.8 | - | - | - | - | Upgrade
|
| Cost of Revenue | 5.22 | 1.18 | - | 0.39 | 0.21 | Upgrade
|
| Gross Profit | 11.58 | -1.18 | - | -0.39 | -0.21 | Upgrade
|
| Selling, General & Admin | 41.43 | 6.39 | 4.28 | 1.93 | 0.63 | Upgrade
|
| Research & Development | - | - | 2.58 | - | - | Upgrade
|
| Amortization of Goodwill & Intangibles | 1.56 | - | - | - | - | Upgrade
|
| Operating Expenses | 42.99 | 6.39 | 6.86 | 1.93 | 0.63 | Upgrade
|
| Operating Income | -31.41 | -7.57 | -6.86 | -2.32 | -0.84 | Upgrade
|
| Interest Expense | -3.01 | -0.79 | -0.52 | -0.14 | -0 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.4 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -14.98 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -49.4 | -7.96 | -7.38 | -2.46 | -0.84 | Upgrade
|
| Merger & Restructuring Charges | -1.02 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.29 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.24 | Upgrade
|
| Pretax Income | -50.71 | -7.96 | -7.38 | -2.46 | -0.6 | Upgrade
|
| Income Tax Expense | -7.39 | - | - | - | - | Upgrade
|
| Net Income | -43.32 | -7.96 | -7.38 | -2.46 | -0.6 | Upgrade
|
| Net Income to Common | -43.32 | -7.96 | -7.38 | -2.46 | -0.6 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | 237.34% | 336.69% | 193.25% | - | - | Upgrade
|
| EPS (Basic) | -23.04 | -14.27 | -57.82 | -56.48 | - | Upgrade
|
| EPS (Diluted) | -23.04 | -14.27 | -57.82 | -56.48 | - | Upgrade
|
| Free Cash Flow | -22.69 | -5.79 | -0.98 | -1.57 | -1.59 | Upgrade
|
| Free Cash Flow Per Share | -12.06 | -10.39 | -7.68 | -36.00 | - | Upgrade
|
| Gross Margin | 68.94% | - | - | - | - | Upgrade
|
| Operating Margin | -187.01% | - | - | - | - | Upgrade
|
| Profit Margin | -257.93% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -135.09% | - | - | - | - | Upgrade
|
| EBITDA | -29.12 | - | - | -1.63 | - | Upgrade
|
| EBITDA Margin | -173.40% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 2.29 | - | - | 0.69 | - | Upgrade
|
| EBIT | -31.41 | -7.57 | -6.86 | -2.32 | -0.84 | Upgrade
|
| EBIT Margin | -187.01% | - | - | - | - | Upgrade
|
| Revenue as Reported | 16.8 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.